Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on modern management of frailty

LIVE: Thursday 17th October 2024, 18:00-19:30 (CEST)

Frailty has a significant impact on health and wellbeing, especially in older adults. Join our experts to understand the factors that contribute to the development of frailty and find out how to manage the condition and reduce the risk of disability, dependency, and mortality.
ADVANCED SEARCH
Log in
Top

Current Treatment Options in Oncology

2000 - 2024
Volumes
192
Issues
Chevron right icon
Issue 9/2024
Latest issue

Current Treatment Options in Oncology OnlineFirst articles

Tarlatamab-dlle: A New Hope for Patients with Extensive-Stage Small-Cell Lung Cancer

  • REVIEW

Updates in Systemic Treatment of Hormone Receptor-Positive Early-Stage Breast Cancer

The Role of SIRT1 in Leukemia

Clinical Trial Data Review of the Combination FTD/TPI + Bevacizumab in the Treatment Landscape of Unresectable Metastatic Colorectal Cancer

Correction to: Treatment of Anemia in Lower-Risk Myelodysplastic Syndrome

Pulmonary toxicities of NSCLC systemic therapy

  • Open Access
  • NSCLC
  • Review

Diagnosis and Treatment of Myxoid Liposarcoma

The Role of Nursing in the Delivery of Cardio-Oncology

Research Progress on Ferroptosis in Multiple Myeloma

Myeloproliferative Neoplasms and Cardiovascular Disease: A Review

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

About this journal

Current Treatment Options in Oncology offers in-depth review articles contributed by international experts on the most significant developments in the field. By providing clear, insightful, balanced review articles that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the treatment of cancer.

Metadata
Title
Current Treatment Options in Oncology
Coverage
Volume 1/2000 - Volume 25/2024
Publisher
Springer US
Electronic ISSN
1534-6277
Print ISSN
1527-2729
Journal ID
11864
DOI
https://doi.org/10.1007/11864.1534-6277

2024 ESMO Congress

Add-on Ra223 could be a new first-line option in mCRPC

Adding radium-223 to first-line enzalutamide significantly improves the survival of patients with bone metastatic castration-resistant prostate cancer.

Read more

AI model can predict tumor mutations

No OS benefit of adding preoperative CRT in gastric cancer

T-DXd supported for breast cancer with brain metastases

» View more highlights on the ESMO 2024 hub page

SPONSORED

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

  • Webinar | 01-10-2024 | 12:30 (CEST)

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by:
  • Novartis Pharma AG
Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Get a reminder for the on-demand version
Image Credits